Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chemed Inc (CHE)

Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,214,114
  • Shares Outstanding, K 15,139
  • Annual Sales, $ 2,264 M
  • Annual Income, $ 272,510 K
  • 60-Month Beta 0.46
  • Price/Sales 3.64
  • Price/Cash Flow 22.19
  • Price/Book 6.97
Trade CHE with:

Options Overview Details

View History
  • Implied Volatility 17.56% ( -0.05%)
  • Historical Volatility 12.73%
  • IV Percentile 53%
  • IV Rank 39.57%
  • IV High 23.17% on 10/19/23
  • IV Low 13.89% on 05/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 63
  • Open Int (30-Day) 98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 5.14
  • Number of Estimates 2
  • High Estimate 5.22
  • Low Estimate 5.05
  • Prior Year 4.71
  • Growth Rate Est. (year over year) +9.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
529.84 +2.40%
on 06/20/24
557.70 -2.71%
on 06/03/24
-0.76 (-0.14%)
since 05/28/24
3-Month
529.84 +2.40%
on 06/20/24
642.68 -15.58%
on 04/01/24
-99.35 (-15.48%)
since 03/28/24
52-Week
492.84 +10.09%
on 09/13/23
654.62 -17.12%
on 03/15/24
+6.29 (+1.17%)
since 06/28/23

Most Recent Stories

More News
Chemed: Q1 Earnings Snapshot

Chemed: Q1 Earnings Snapshot

CHE : 542.58 (-0.43%)
Chemed: Q4 Earnings Snapshot

Chemed: Q4 Earnings Snapshot

CHE : 542.58 (-0.43%)
Chemed: Q3 Earnings Snapshot

Chemed: Q3 Earnings Snapshot

CHE : 542.58 (-0.43%)
Chemed: Q2 Earnings Snapshot

Chemed: Q2 Earnings Snapshot

CHE : 542.58 (-0.43%)
Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2023 Health Care Conference on Wednesday, May 10, 2023, at 10:40 AM (PDT) at the Encore...

CHE : 542.58 (-0.43%)
Chemed: Q1 Earnings Snapshot

Chemed: Q1 Earnings Snapshot

CHE : 542.58 (-0.43%)
Chemed Reports First-Quarter 2023 Results

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial...

CHE : 542.58 (-0.43%)
Chemed To Report First-Quarter 2023 Earnings April 26, Related Conference Call To Be Held On April 27

Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2023, on Wednesday, April 26, 2023, following the close of trading on the New...

CHE : 542.58 (-0.43%)
Chemed Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 33 rd Annual Healthcare Conference on Tuesday, March 14, 2023, at approximately 1:20 p.m. (ET)....

CHE : 542.58 (-0.43%)
Chemed: Q4 Earnings Snapshot

Chemed: Q4 Earnings Snapshot

CHE : 542.58 (-0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides...

See More

Key Turning Points

3rd Resistance Point 557.26
2nd Resistance Point 552.01
1st Resistance Point 547.30
Last Price 542.58
1st Support Level 537.34
2nd Support Level 532.09
3rd Support Level 527.38

See More

52-Week High 654.62
Fibonacci 61.8% 592.82
Fibonacci 50% 573.73
Fibonacci 38.2% 554.64
Last Price 542.58
52-Week Low 492.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar